Clinical Trials Directory

Trials / Completed

CompletedNCT05034900

Does Addition of Oscillatory Positive Expiratory Pressure (OPEP) Device to a Chest Physiotherapy Program Provide Further Health Benefits in Children With Bronchiectasis?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Izmir Bakircay University · Academic / Other
Sex
All
Age
8 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Oscillatory positive expiratory pressure (OPEP) devices such as Flutter®, Aerobika® or Shaker ® are commonly prescribed in the clinical practice for airway clearance in children with chronic lung diseases including bronchiectasis, cystic fibrosis, and primary ciliary dyskinesia. Health insurance companies may cover these devices in some countries; but this is not a common practice around the world. Therefore, many families have to purchase these devices themselves. Unfortunately, these devices are rather expensive especially in the developing countries and consequently, families become financially burdened. Aim of this study is to investigate whether the addition of OPEP devices to a comprehensive chest physiotherapy program provide additional benefits on pulmonary function and exercise capacity in children with bronchiectasis. Results of this study may help better interpreting the cost-effectiveness of these devices.

Conditions

Interventions

TypeNameDescription
OTHERChest physiotherapyProgramme will include diaphragmatic breathing exercise, thoracic expansion exercises, postural drainage and coughing techniques.
DEVICEOscillatory Positive Expiratory Pressure (OPEP) deviceShaker® device will be used.

Timeline

Start date
2021-09-06
Primary completion
2022-09-15
Completion
2022-09-15
First posted
2021-09-05
Last updated
2022-09-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05034900. Inclusion in this directory is not an endorsement.